Beclometasone monodose nebuliser solution - Chiesi

Drug Profile

Beclometasone monodose nebuliser solution - Chiesi

Alternative Names: BDP UDV; Clenil A

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi Farmaceutici
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma
  • No development reported Rhinosinusitis

Most Recent Events

  • 02 Sep 2016 No development reported - Phase-III for Rhinosinusitis (Adjunctive treatment) in Italy (Inhalation)
  • 24 Apr 2014 Chiesi completes the phase III CLEAR trial in acute Rhinosinusitis (adjunctive-treatment) in Italy (EudraCT2011-001459-35)
  • 31 Dec 2013 Launched for Asthma in China (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top